In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the ... trading as the trade war escalates between the US and China. Trump’s tariff bonanza doesn’t look set to ...

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

But increasingly American venture capitalists are building U.S.-based companies from scratch to test and ultimately seek to commercialize innovative drugs developed in China. Most recently ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

China has embraced CRISPR gene editing, leapfrogged the West in cell therapy, developed sophisticated animal models and rapidly expanded its biotech exports from near-zero in 2016 to nearly 30% of ...